The title compound was obtained by the cyclization of 4-ethyl-l-{[(4-methyl-4/i-l,2,4-triazol-3-yl) 
Source of material
The title compound was obtained by the cyclization of 4-ethyl-l-{[(4-methyl-4/i-l,2,4-triazol-3-yl)sulfanyl]acetyl}thiosemi-carbazide in 2 % aqueous solution of NaOH at room temperature for five days [1] . Recrystallization of the compound from the methanol, ethanol and propan-2-ol solutions yielded colorless crystals of two modifications: the plate-shaped crystals of monoclinic form [1] (m.p. 451K) and the needle-shaped crystals of this study (m.p. 454 K).
Experimental details
The value of the Flack parameter of 0.05(2) indicated the correct absolute structure.
Discussion
Hie orthorhombic polymorph presented here is the second modification of previously reported structure of 4-ethyl-5-{[(4-methyl-4/M,2,4-triazol-3-yl>sulfanyl]methyl}-4#-l,2,4-triazole-3(2/f)-thione [1] , The molecules in both polymorphs exhibit nearly equal bond lengths and angles (within 3σ), but adopt different conformations, thus, this is a case of conformational polymorphism (figure, top). In the AH-1,2,4-triazole system of the orthorhombic form the N2-C3 and N1-C5 bond lengths , bottom) . In contrast to the orthorhombic polymorph, the molecules of the monoclinic crystal structure [1] , connected by short N11-H-S2 (</(N-S) = 3.312 A, Z.N-H-S = 175°) hydrogen bonds, form centrosymmetric dimers. 
